The cell line development market is growing at a CAGR of approximately 8-10% due to the increasing adoption of cell-based ...

MK-1084, Merck’s investigational KRAS G12C inhibitor, showed a manageable safety profile along with antitumor activity in the ...

Immatics’ cell therapy has been linked to a 56% objective response rate (ORR) among 32 heavily pretreated patients with ...

This country research report on Vietnam Primary Cell Culture Market offers comprehensive insights into the market landscape, customer intelligence, and competitive strategies in the Vietnam market.

SaveHealth provides an in-depth look at cholesterol-fighting atorvastatin, its mechanism of action, clinical significance, ...

Merck KGaA has shown off data that fueled its $85 million bet on a late-phase treatment for a rare, locally aggressive tumor.

Zynyz is the first and only FDA-approved first-line treatment for adult patients with inoperable locally recurrent or ...

Researchers developed a new machine learning method that, given a relevant amino acid sequence, can automatically predict the location of a protein in any human cell line down to the single-cell level ...

During a live event, Konstantinos Sdrimas, MD, asked participants what community oncologists should consider when referring ...